ACRV
Acrivon Therapeutics, Inc. Common Stock
stockNASDAQ
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the foundational science is based on proven, pathway-based methods linking active disease-driving mechanisms with the drug mechanism-of-action, to precisely match the therapy with patients who will benefit. our method is applicable across drug modalities
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.61 | 2026-11-06 | -9.94% | 0.989 |
| 1M | 1.75 | 2026-10-13 | -17.14% | 2.090 |
| 3M | 1.85 | 2026-08-13 | -21.62% | 2.054 |
| 6M | 1.92 | 2026-05-13 | -24.48% | 1.989 |
| 1Y | 2.07 | 2025-11-13 | -29.95% | 1.919 |
| 2Y | 7.93 | 2024-11-13 | -81.72% | — |
| 5Y | 16.64 | 2022-11-15 | -91.29% | 1.569 |
Acrivon Therapeutics, Inc. Common Stock (NASDAQ:ACRV) stock price today is $1.45, and today's volume is 199,755. ACRV is down 0.685% today. The 30 day average volume is 213,830. ACRV market cap is $62.14M with 42.85M shares outstanding.